Research and Markets: Russian Federation Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/9b2ba3/russian_federation) has announced the addition of GlobalData 's new report "Russian Federation Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery" to their offering.

“Russian Federation Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery”

GlobalData's new report, Russian Federation Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery provides key market data on the Russian Federation Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories - Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Scope

Market size and company share data for Diabetes Care Devices market categories - Glucose Monitoring and Insulin Delivery.
Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
2010 company shares and distribution shares data for each of the two market categories.
Global corporate-level profiles of key companies operating within the Russian Federation Diabetes Care Devicesmarket.
Key players covered include F. Hoffmann-La Roche Ltd., Sanofi, Eli Lilly and Company, LifeScan, Inc., Novo Nordisk A/S, Becton, Dickinson and Company and others.

Companies Mentioned: